Main

processing priority

4

site type

0 (generic, awaiting analysis)

review version

11

html import

20 (imported)

Events

first seen date

2024-01-10 23:35:02

expired found date

-

created at

2024-06-23 17:08:12

updated at

2026-01-05 20:25:51

Domain name statistics

length

15

crc

53543

tld

2211

nm parts

0

nm random digits

0

nm rare letters

0

Connections

is subdomain of id

-

previous id

0

replaced with id

0

related id

-

dns primary id

173561409

dns alternative id

0

lifecycle status

0 (unclassified, or currently active)

Subdomains and pages

deleted subdomains

0

page imported products

0

page imported random

0

page imported parking

0

Error counters

count skipped due to recent timeouts on the same server IP

0

count content received but rejected due to 11-799

0

count dns errors

0

count cert errors

0

count timeouts

0

count http 429

0

count http 404

0

count http 403

0

count http 5xx

0

next operation date

-

Server

server bits

server ip

-

Mainpage statistics

mp import status

20

mp rejected date

-

mp saved date

-

mp size orig

119699

mp size raw text

5008

mp inner links count

5

mp inner links status

20 (imported)

Open Graph

title

InDex Pharmaceuticals

description

InDex Pharmaceuticals Holding AB (publ) is the parent company of the Group, which also includes InDex Pharmaceuticals AB and InDex Pharmaceuticals AB’s wholly owned subsidiary InDex Diagnostics AB.

site name

InDex Pharmaceuticals

author

updated

2026-01-01 01:01:14

raw text

InDex Pharmaceuticals Loading... SVE ENG About Us About Us Close InDex Pharmaceuticals in brief CEO corner Business model Corporate governance General meetings Nomination committee Board of directors Work of the board of directors Management Remuneration and incentive programmes Auditors Articles of association Advisory Board North America Advisory Board Europe Research & Development Research & Development Close Technology platform & pipeline Scientific articles Cobitolimod About ulcerative colitis and today's standard of care A new opportunity with cobitolimod Clinical studies Phase III program CONCLUDE Questions and answers on CONCLUDE CONDUCT The CONDUCT study Study design Frequently asked questions about CONDUCT Ulcerative Colitis Ulcerative Colitis Close About ulcerative colitis and today's standard of care Living with ulcerative colitis - read patient stories About cobitolimod Phase III program CO...

Text analysis

redirect type

0 (-)

block type

0 (no issues)

detected language

1 (English)

category id

Economy [en] (222)

index version

2025123101

spam phrases

0

Text statistics

text nonlatin

0

text cyrillic

0

text characters

3833

text words

617

text unique words

221

text lines

200

text sentences

6

text paragraphs

0

text words per sentence

102

text matched phrases

2

text matched dictionaries

3

RSS

rss path

rss status

1 (priority 1 already searched, no matches found)

rss found date

-

rss size orig

0

rss items

0

rss spam phrases

0

rss detected language

0 (awaiting analysis)

inbefore feed id

-

inbefore status

0 (new)

Sitemap

sitemap status

10 (sitemap found, awaiting processing)

sitemap review version

2

sitemap urls count

1

sitemap urls adult

0

sitemap filtered products

0

sitemap filtered videos

0

sitemap found date

2024-01-10 23:35:02

sitemap process date

-

sitemap first import date

-

sitemap last import date

-